Cyclacel Pharmaceuticals's total assets for Q2 2025 were $4.40K, a decrease of -99.88% from the previous quarter. CYCC total liabilities were $770.00 for the fiscal quarter, a -99.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.